Stay updated on T-DXd in HER2 Expressing Tumors Clinical Trial

Sign up to get notified when there's something new on the T-DXd in HER2 Expressing Tumors Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the T-DXd in HER2 Expressing Tumors Clinical Trial page

  1. Check
    today
    No Change Detected
  2. Check
    yesterday
    No Change Detected
  3. Check
    2 days ago
    Change Detected
    Summary
    The value of Revision has been updated from v2.8.0 to v2.8.1, indicating a recent revision in the content of the webpage.
    Difference
    0.1%
    Check dated 2024-06-13T23:26:01.000Z thumbnail image
  4. Check
    3 days ago
    No Change Detected
  5. Check
    4 days ago
    No Change Detected
  6. Check
    10 days ago
    Change Detected
    Summary
    The value on the webpage has changed from 7 to 8, indicating a potential update or modification in the context of a Phase 2 study evaluating the efficacy and safety of trastuzumab deruxtecan (T-DXd) for the treatment of selected HER2-expressing tumors in various cancer types.
    Difference
    0.1%
    Check dated 2024-06-06T14:53:04.000Z thumbnail image
  7. Check
    23 days ago
    Change Detected
    Summary
    The value (Estimated) on the webpage has recently changed to . This change likely indicates an update or revision in the estimated completion date for a Phase 2 study evaluating the efficacy and safety of trastuzumab deruxtecan (T-DXd) for selected HER2-expressing tumors in various cohorts.
    Difference
    0.0%
    Check dated 2024-05-24T04:05:12.000Z thumbnail image
  8. Check
    24 days ago
    Change Detected
    Summary
    The study status has changed from 'Active, not recruiting' to 'Recruiting,' with an updated estimated primary completion date of July 30, 2027. Additionally, new contact information and site statuses have been provided, including several sites in California now listed as 'Withdrawn.'
    Difference
    48%
    Check dated 2024-05-22T21:38:44.000Z thumbnail image
  9. Check
    46 days ago
    Change Detected
    Difference
    0.9%
    Check dated 2024-04-30T22:35:07.000Z thumbnail image

Stay in the know with updates to T-DXd in HER2 Expressing Tumors Clinical Trial

Enter your email address, and we'll notify you when there's something new on the T-DXd in HER2 Expressing Tumors Clinical Trial page.